Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate. 1977

B Eriksson, and E Helgstrand, and N G Johansson, and A Larsson, and A Misiorny, and J O Norén, and L Philipson, and K Stenberg, and G Stening, and S Stridh, and B Oberg

Ribavirin 5'-triphosphate (RTP), derived from the broad-spectrum antiviral compound ribavirin (Virazole), can selectively inhibit influenza virus ribonucleic acid polymerase in a cell-free assay. Ribavirin and its 5'-monophosphate have no effect on the polymerase. The inhibition is competitive with respect to adenosine 5'-triphosphate and guanosine 5'-triphosphate. RTP also inhibits ApG- and GpC-stimulated influenza virus ribonucleic acid polymerase. Since ribavirin is phosphorylated in the cell, the inhibition of influenza multiplication in the cell may also be caused by RTP.

UI MeSH Term Description Entries
D009943 Organophosphorus Compounds Organic compounds that contain phosphorus as an integral part of the molecule. Included under this heading is broad array of synthetic compounds that are used as PESTICIDES and DRUGS. Organophosphorus Compound,Organopyrophosphorus Compound,Organopyrophosphorus Compounds,Compound, Organophosphorus,Compound, Organopyrophosphorus,Compounds, Organophosphorus,Compounds, Organopyrophosphorus
D009980 Influenza A virus The type species of the genus ALPHAINFLUENZAVIRUS that causes influenza and other diseases in humans and animals. Antigenic variation occurs frequently between strains, allowing classification into subtypes and variants. Transmission is usually by aerosol (human and most non-aquatic hosts) or waterborne (ducks). Infected birds shed the virus in their saliva, nasal secretions, and feces. Alphainfluenzavirus influenzae,Avian Orthomyxovirus Type A,FLUAV,Fowl Plague Virus,Human Influenza A Virus,Influenza Virus Type A,Influenza Viruses Type A,Myxovirus influenzae-A hominis,Myxovirus influenzae-A suis,Myxovirus pestis galli,Orthomyxovirus Type A,Orthomyxovirus Type A, Avian,Orthomyxovirus Type A, Human,Orthomyxovirus Type A, Porcine,Pestis galli Myxovirus,Fowl Plague Viruses,Influenza A viruses,Myxovirus influenzae A hominis,Myxovirus influenzae A suis,Myxovirus, Pestis galli,Myxoviruses, Pestis galli,Pestis galli Myxoviruses,Plague Virus, Fowl,Virus, Fowl Plague
D012254 Ribavirin A nucleoside antimetabolite antiviral agent that blocks nucleic acid synthesis and is used against both RNA and DNA viruses. Ribovirin,Tribavirin,ICN-1229,Rebetol,Ribamide,Ribamidil,Ribamidyl,Ribasphere,Vilona,Viramide,Virazide,Virazole,ICN 1229,ICN1229
D012263 Ribonucleosides Nucleosides in which the purine or pyrimidine base is combined with ribose. (Dorland, 28th ed)
D012321 DNA-Directed RNA Polymerases Enzymes that catalyze DNA template-directed extension of the 3'-end of an RNA strand one nucleotide at a time. They can initiate a chain de novo. In eukaryotes, three forms of the enzyme have been distinguished on the basis of sensitivity to alpha-amanitin, and the type of RNA synthesized. (From Enzyme Nomenclature, 1992). DNA-Dependent RNA Polymerases,RNA Polymerases,Transcriptases,DNA-Directed RNA Polymerase,RNA Polymerase,Transcriptase,DNA Dependent RNA Polymerases,DNA Directed RNA Polymerase,DNA Directed RNA Polymerases,Polymerase, DNA-Directed RNA,Polymerase, RNA,Polymerases, DNA-Dependent RNA,Polymerases, DNA-Directed RNA,Polymerases, RNA,RNA Polymerase, DNA-Directed,RNA Polymerases, DNA-Dependent,RNA Polymerases, DNA-Directed
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

B Eriksson, and E Helgstrand, and N G Johansson, and A Larsson, and A Misiorny, and J O Norén, and L Philipson, and K Stenberg, and G Stening, and S Stridh, and B Oberg
January 1968, Antimicrobial agents and chemotherapy,
B Eriksson, and E Helgstrand, and N G Johansson, and A Larsson, and A Misiorny, and J O Norén, and L Philipson, and K Stenberg, and G Stening, and S Stridh, and B Oberg
February 1966, The Journal of biological chemistry,
B Eriksson, and E Helgstrand, and N G Johansson, and A Larsson, and A Misiorny, and J O Norén, and L Philipson, and K Stenberg, and G Stening, and S Stridh, and B Oberg
October 1979, The Biochemical journal,
B Eriksson, and E Helgstrand, and N G Johansson, and A Larsson, and A Misiorny, and J O Norén, and L Philipson, and K Stenberg, and G Stening, and S Stridh, and B Oberg
May 1963, The Journal of biological chemistry,
B Eriksson, and E Helgstrand, and N G Johansson, and A Larsson, and A Misiorny, and J O Norén, and L Philipson, and K Stenberg, and G Stening, and S Stridh, and B Oberg
September 1970, Journal of virology,
B Eriksson, and E Helgstrand, and N G Johansson, and A Larsson, and A Misiorny, and J O Norén, and L Philipson, and K Stenberg, and G Stening, and S Stridh, and B Oberg
September 1968, The Biochemical journal,
B Eriksson, and E Helgstrand, and N G Johansson, and A Larsson, and A Misiorny, and J O Norén, and L Philipson, and K Stenberg, and G Stening, and S Stridh, and B Oberg
July 1966, The Biochemical journal,
B Eriksson, and E Helgstrand, and N G Johansson, and A Larsson, and A Misiorny, and J O Norén, and L Philipson, and K Stenberg, and G Stening, and S Stridh, and B Oberg
July 1981, Biochemical pharmacology,
B Eriksson, and E Helgstrand, and N G Johansson, and A Larsson, and A Misiorny, and J O Norén, and L Philipson, and K Stenberg, and G Stening, and S Stridh, and B Oberg
July 1970, Infection and immunity,
B Eriksson, and E Helgstrand, and N G Johansson, and A Larsson, and A Misiorny, and J O Norén, and L Philipson, and K Stenberg, and G Stening, and S Stridh, and B Oberg
January 1968, Journal of virology,
Copied contents to your clipboard!